GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a major focus in therapeutic investigation, largely due to its impressive impact on managing conditions such as type 2 diabetes and weight gain. Ongoing research have revealed that in addition to glucose regulation